India Surgeon Warns GLP-1 Misuse Risks Weight Regain and Side Effects as Wedding Demand Surges
Updated
Updated · Hindustan Times · Jun 17
India Surgeon Warns GLP-1 Misuse Risks Weight Regain and Side Effects as Wedding Demand Surges
1 articles · Updated · Hindustan Times · Jun 17
Summary
Gurugram bariatric surgeon Anshuman Kaushal warned that Indians are increasingly using GLP-1 drugs such as semaglutide and tirzepatide through unregulated channels for rapid cosmetic weight loss.
Wedding pressure, celebrity transformations and social-media wellness trends are driving the surge, with some clinics reportedly bundling the injections into pre-wedding slimming and beauty packages.
GLP-1 medicines were developed for type 2 diabetes and can aid weight loss under medical supervision, especially for patients with obesity, hypertension, fatty liver disease or sleep apnea.
Unsupervised use can trigger nausea, vomiting, diarrhoea, constipation and stomach pain, while some users may face more serious reactions that require dose monitoring and physician follow-up.
Kaushal said the drugs are not a shortcut: without diet, exercise, sleep and other long-term lifestyle changes, users can regain lost weight after stopping treatment.
Is your wedding weight loss drug a medical miracle or a dangerous fake from the black market?
Beyond nausea, what paralyzing gut condition are users risking for pre-wedding weight loss?
The GLP-1 Explosion in India: Market Drivers, Misuse Risks, and Regulatory Crackdown Amid a Looming Obesity Crisis
Overview
India's weight-loss market is booming as numerous drugmakers compete to supply GLP-1 drugs, which are now seen as powerful solutions for both obesity and diabetes. This surge is fueled by a rapidly growing obesity epidemic, with projections showing over 440 million overweight or obese Indians by 2050. Alongside public health needs, unique societal pressures—such as the desire for better aesthetics and preparation for major life events like weddings—are driving demand. The intense competition and rising use of GLP-1 medications highlight both the urgent health challenges and the shifting cultural attitudes toward weight management in India.